Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
CTXR
$0.59
-2.18%
CTXR
· Citius Pharmaceuticals, Inc.
$0.59
-0.01 (-2.18%)
At close · Aug 31
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We will need to raise additional capital in the future to support our operations beyond November 2026, which raises substantial doubt about the Company's ability to continue as a going concern within one year after the date that the accompanying consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$16.53M
Shares
27.45M
All earnings calls
Earnings call · FY2024 Q2
Citius Pharmaceuticals, Inc. (CTXR) Q2 2024 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Diluted EPS
-$1.34
Net income
-$8.54M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed May 14, 2024 · complete as-filed document
SEC periodic report
10-Q report
Filed May 14, 2024 · complete as-filed document